Hostname: page-component-8448b6f56d-c4f8m Total loading time: 0 Render date: 2024-04-25T05:21:58.566Z Has data issue: false hasContentIssue false
  • English
  • Français

Improving fluoroquinolone use in the outpatient setting using a patient safety initiative

Published online by Cambridge University Press:  17 August 2018

Kazuaki Jindai Open the ORCID record for Kazuaki Jindai [Opens in a new window] ,
Michihiko Goto Open the ORCID record for Michihiko Goto [Opens in a new window] ,
Kimberly MacKay ,
Graeme N. Forrest ,
Jackson Musuuza ,
Nasia Safdar  and
Christopher D. Pfeiffer
Kazuaki Jindai*
Affiliation:
School of Public Health, Oregon Health and Science University, Portland, Orego Department of Hospital and Specialty Medicine, Veterans Affairs Portland Health Care System, Portland, Oregon
Michihiko Goto
Affiliation:
Iowa City Veterans Affairs Medical Center, Iowa City, Iowa Division of Infectious Diseases, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa
Kimberly MacKay
Affiliation:
Department of Hospital and Specialty Medicine, Veterans Affairs Portland Health Care System, Portland, Oregon
Graeme N. Forrest
Affiliation:
Department of Hospital and Specialty Medicine, Veterans Affairs Portland Health Care System, Portland, Oregon Division of Infectious Disease, Department of Medicine, Oregon Health and Science University, Portland, Oregon
Jackson Musuuza
Affiliation:
Institute of Clinical and Translational Research, University of Wisconsin, Madison, Wisconsin
Nasia Safdar
Affiliation:
Division of Infectious Disease, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin The William S. Middleton VA Medical Center, Madison, Wisconsin
Christopher D. Pfeiffer
Affiliation:
Department of Hospital and Specialty Medicine, Veterans Affairs Portland Health Care System, Portland, Oregon Division of Infectious Disease, Department of Medicine, Oregon Health and Science University, Portland, Oregon
*
*Author for correspondence: Kazuaki Jindai, MD, MPH, 1-2-2 Kasumigaseki, Chiyoda-ku, Tokyo, 100-8916 Japan. E-mail: jindaik@who.int
Get access Rights & Permissions [Opens in a new window]

Abstract

We analyzed the impact of a fluoroquinolone patient safety initiative on the weekly fluoroquinolone prescription rate in Veterans Affairs community-based outpatient clinics. We observed a significant initial but unsustained reduction. Such an initiative can function as an antimicrobial stewardship intervention; however, strategies to promote sustainability should be explored.

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 39 , Issue 9 , September 2018 , pp. 1108 - 1111
Copyright
© 2018 by The Society for Healthcare Epidemiology of America. All rights reserved. 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

a

Present affiliation: K.J. is now affiliated with Infectious Disease Control Division, Health Service Bureau, Ministry of Health, Labour and Welfare, Tokyo, Japan.

PREVIOUS PRESENTATION: Part of this study was presented at The Society for Healthcare Epidemiology of America Spring 2016 conference in Atlanta, Georgia, on May 20, 2016.

Cite this article: Jindai K, et al. (2018). Improving fluoroquinolone use in the outpatient setting using a patient safety initiative. Infection Control & Hospital Epidemiology 2018, 39, 1108–1111. doi: 10.1017/ice.2018.169

References

1. Kabbani, S, Hersh, AL, Shapiro, DJ, Fleming-Dutra, KE, Pavia, AT, Hicks, LA. Opportunities to improve fluoroquinolone prescribing in the United States for adult ambulatory care visits. Clin Infect Dis 2018;67:134–136.Google Scholar
2. Stewardson, AJ, Vervoort, J, Adriaenssens, N, et al. Effect of outpatient antibiotics for urinary tract infections on antimicrobial resistance among commensal Enterobacteriaceae: a multinational prospective cohort study. Clin Microbiol Infect 2018. doi: 10.1016/j.cmi.2017.12.026.Google Scholar
3. Dingle, KE, Didelot, X, Quan, TP, et al. Effects of control interventions on Clostridium difficile infection in England: an observational study. Lancet Infect Dis 2017;17:411–421.Google Scholar
4. FDA Drug Safety Communication: FDA advises restricting fluoroquinolone antibiotic use for certain uncomplicated infections; warns about disabling side effects that can occur together. US Food and Drug Administration website. http://www.fda.gov/Drugs/DrugSafety/ucm500143.htm. Published 2016. Accessed January 30, 2018.Google Scholar
5. Department of Veterans Affairs Office of Inspector General. Community Based outpatient clinic and primary care clinic reviews at Portland VA Medical Center Portland, Oregon. Department of Veterans Affairs website. http://www.va.gov/oig/pubs/VAOIG-13-03417-34.pdf. Published 2014. Accessed April 1, 2017.Google Scholar
6. Meeker, D, Linder, JA, Fox, CR, et al. Effect of behavioral interventions on inappropriate antibiotic prescribing among primary care practices: a randomized clinical trial. JAMA 2016;315:562–570.Google Scholar
7. Persell, SD, Doctor, JN, Friedberg, MW, et al. Behavioral interventions to reduce inappropriate antibiotic prescribing: a randomized pilot trial. BMC Infect Dis 2016;16:373.Google Scholar
8. Gerber, JS, Prasad, PA, Fiks, AG, et al. Effect of an outpatient antimicrobial stewardship intervention on broad-spectrum antibiotic prescribing by primary care pediatricians: a randomized trial. JAMA 2013;309:2345–2352.Google Scholar
9. Suda, KJ, Hicks, LA, Roberts, RM, Hunkler, RJ, Taylor, TH. Trends and seasonal variation in outpatient antibiotic prescription rates in the United States, 2006 to 2010. Antimicrob Agents Chemother 2014;58:2763–2766.Google Scholar
10. Ancker, JS, Edwards, A, Nosal, S, et al. Effects of workload, work complexity, and repeated alerts on alert fatigue in a clinical decision support system. BMC Med Informat Decis Making 2017;17:36.Google Scholar